The membrane as a target for controlling hypervirulent Clostridium difficile infections.
about
The Clostridium difficile proline racemase is not essential for early logarithmic growth and infection.Action of nitroheterocyclic drugs against Clostridium difficile.Progress in the discovery of treatments for C. difficile infection: A clinical and medicinal chemistry review.A curated C. difficile strain 630 metabolic network: prediction of essential targets and inhibitors.Mutations associated with reduced surotomycin susceptibility in Clostridium difficile and Enterococcus speciesGastrointestinal localization of metronidazole by a lactobacilli-inspired tetramic acid motif improves treatment outcomes in the hamster model of Clostridium difficile infection.Reprofiled anthelmintics abate hypervirulent stationary-phase Clostridium difficile.Prospects for flavonoid and related phytochemicals as nature-inspired treatments for Clostridium difficile infection.Diarylacylhydrazones: Clostridium-selective antibacterials with activity against stationary-phase cellsChemical Genomics, Structure Elucidation, and in Vivo Studies of the Marine-Derived Anticlostridial Ecteinamycin.Mode of action and bactericidal properties of surotomycin against growing and nongrowing Clostridium difficile.Role of Biorelevant Dissolution Media in the Selection of Optimal Salt Forms of Oral Drugs: Maximizing the Gastrointestinal Solubility and in Vitro Activity of the Antimicrobial Molecule, Clofazimine.
P2860
Q33827570-91E04D11-B05D-4166-ABEE-EFBDE2847CB3Q34276271-28230BDA-18E4-418A-86FD-37DEC96C7B49Q35044119-9B8E6C65-ED14-45F6-87ED-AD4B76B80579Q35332572-A0709340-8320-4F17-BFDE-0FC3849BA460Q35746268-A31AEFE9-3246-4832-A2EE-6F50F6076174Q36367042-6C3FEFC4-2376-4EC8-812D-28FD8866435DQ37260627-DEEC2447-9F2A-4CEB-AF7A-7A0B56954BF5Q37542440-A0403BD1-CDEF-49B9-AED5-E95848CE50C5Q37550108-A02B9A2F-F7F4-4793-A04F-CEE1F72D2613Q38679129-B15D2297-6A76-485A-9C6D-0E3FD5C4ED86Q41175414-2AE23A3C-2A1F-423E-93E0-685911F7E7D8Q55664963-3F9979DF-052E-4641-8B35-8BE234439318
P2860
The membrane as a target for controlling hypervirulent Clostridium difficile infections.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The membrane as a target for controlling hypervirulent Clostridium difficile infections.
@en
type
label
The membrane as a target for controlling hypervirulent Clostridium difficile infections.
@en
prefLabel
The membrane as a target for controlling hypervirulent Clostridium difficile infections.
@en
P2093
P2860
P356
P1476
The membrane as a target for controlling hypervirulent Clostridium difficile infections.
@en
P2093
Julian G Hurdle
Philip T Cherian
Xiaoqian Wu
P2860
P304
P356
10.1093/JAC/DKS493
P407
P50
P577
2012-12-21T00:00:00Z